exhibit 10. 1 special report this report is published by misonix, inc. ( “ misonix ” or the “ company ” ) to provide the investor with a general review of the company ’ s technology and growth prospects for various products. this report supplements some of the information that is available in the company ’ s form 10 - k and related documents. except for historical information contained herein, the matters discussed in this report contain forward - looking statements. the accuracy of these statements is subject to significant risks and uncertainties. actual results could differ materially from those contained in the forward - looking statements. december 1, 2010 technology and growth status report misonix develops, manufactures and markets ultrasonic medical devices for special surgery and laboratory equipment. the company ’ s medical systems are used for spine surgery, neurosurgery, general surgery, maxillofacial surgery, cosmetic surgery and surgical wound debridement. the company was founded in 1959 and has executive offices and production facilities in farmingdale, n. y. symbol : mson — price : $ 2. 30 52 - week price range : $ 1. 61 - $ 3. 84 shares outstanding : 7, 000, 000 market capitalization : $ 16. 1 million shares held by insiders : approx. 21 % * % held by institutions : 10. 1 % daily trading vol. ( avg ) : 7, 000 sh cash / share ( 9 / 31 / 10 ) $ 1. 35 book val. / share ( 9 / 31 / 10 ) $ 2. 45 fy fy 1q 1q fy ends 6 / 30 2009 2010 ( 9 / 09 ) ( 9 / 10 ) • device sales ( 000 ) $ 9, 688 $ 10, 737 $ 2, 003 $ 2, 692 • lab / other ( 000 ) 3, 025 2, 634 $ 628 $ 566 total sales $ 12, 713 $ 13, 371 $ 2, 631 $ 3, 258 gross profit ( 000 ) $ 5, 218 6, 526 1, 009 1, 637 gross margin : 41. 0 % 48. 8 % 38. 4 % 50. 3 % net income ( 000 ) * * : $ ( 1, 573 ) $ ( 2, 191 ) $ ( 1, 247 ) $ ( 843 ) eps * * $ ( 0. 22 ) $ ( 0. 31 ) $ ( 0